Publications by authors named "I Gorman"

Article Synopsis
  • Psychedelic Harm Reduction and Integration (PHRI) is a clinical model designed to help clients prepare for and integrate psychedelic experiences in a therapeutic context without administering psychedelics.
  • It combines elements from various therapeutic approaches, including harm reduction psychotherapy and mindfulness techniques, to empower clients while addressing both difficult and positive experiences.
  • The model focuses on principles like non-directive approaches and emotional awareness, aiming to facilitate lasting positive change while minimizing potential risks associated with psychedelics.
View Article and Find Full Text PDF

Background: Student debt has become a significant problem for the profession of physical therapy. Higher debt levels can impact mental health and professional and personal decisions. The American Physical Therapy Association (APTA) has recommended improving physical therapy students' financial literacy.

View Article and Find Full Text PDF

The use of psychedelics for various purposes was common in different civilizations throughout human history and has been explored scientifically for more than a century. Although the applications of psychedelics show promise in the treatment of various psychiatric and neurological indications, as well as in facilitation of well-being and personal growth, several psychedelic-related risks and challenges have also been identified. Psychedelic integration (PI) refers to various practices that serve to either minimize harms or maximize benefits associated with psychedelic use.

View Article and Find Full Text PDF

Post-traumatic stress disorder (PTSD) presents a major public health problem for which currently available treatments are modestly effective. We report the findings of a randomized, double-blind, placebo-controlled, multi-site phase 3 clinical trial (NCT03537014) to test the efficacy and safety of 3,4-methylenedioxymethamphetamine (MDMA)-assisted therapy for the treatment of patients with severe PTSD, including those with common comorbidities such as dissociation, depression, a history of alcohol and substance use disorders, and childhood trauma. After psychiatric medication washout, participants ( = 90) were randomized 1:1 to receive manualized therapy with MDMA or with placebo, combined with three preparatory and nine integrative therapy sessions.

View Article and Find Full Text PDF